SHIELD is a new methodology that integrates disproportionality analysis and semantic clustering of adverse event terms to detect safety signals in clinical trials automatically. This approach enhances the identification and interpretation of treatment-associated safety profiles by leveraging natural language processing techniques, providing content creators with advanced tools for analyzing and visualizing complex medical data.
Read the full article at arXiv cs.CL (NLP)
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





